Correlation Engine 2.0
Clear Search sequence regions


  • adenocarcinoma (1)
  • cysts (8)
  • dna (3)
  • humans (1)
  • mirna (1)
  • mirna (2)
  • research (1)
  • transform (1)
  • Sizes of these terms reflect their relevance to your search.

    With increased utilization and ongoing advancements in cross-sectional abdominal imaging, the identification of a pancreatic cyst has become a frequent finding. While many pancreatic cysts are associated with a benign clinical course, others may transform into pancreatic ductal adenocarcinoma. However, distinguishing a benign from a malignant pancreatic cyst or pancreatic cyst with malignant potential on the basis of standard clinical findings, imaging parameters and ancillary studies can be challenging. Hence, a significant interest within the past decade has been the identification of novel biomarkers to accurately classify and prognosticate a pancreatic cyst. Within this review, we discuss novel DNA, miRNA, protein and metabolite biomarkers, and their relevance in clinical practice. In addition, we focus on future areas of research that have the potential to change pancreatic cyst management.

    Citation

    Harkirat Singh, Kevin McGrath, Aatur D Singhi. Novel Biomarkers for Pancreatic Cysts. Digestive diseases and sciences. 2017 Jul;62(7):1796-1807

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 28197742

    View Full Text